Paula Ragan
Gründer bei X4 PHARMACEUTICALS, INC.
Vermögen: 864 527 $ am 30.04.2024
Aktive Positionen von Paula Ragan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
X4 PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.07.2014 | - |
Vorstandsvorsitzender | 01.07.2014 | - | |
Gründer | 01.07.2014 | - | |
Präsident | 01.07.2014 | - | |
Unternehmenssekretär | 13.03.2019 | - | |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 29.10.2019 | - |
Karriereverlauf von Paula Ragan
Ehemalige bekannte Positionen von Paula Ragan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.08.2012 | 01.09.2014 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2007 | 01.08.2012 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | 13.03.2019 | - |
Vorstandsvorsitzender | 13.03.2019 | - | |
Präsident | 13.03.2019 | - | |
Unternehmenssekretär | 13.03.2019 | - | |
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Gründer | 01.07.2014 | - | |
Präsident | - | - | |
St. Lawrence Energy Corp.
St. Lawrence Energy Corp. SemiconductorsElectronic Technology St. Lawrence Energy Corp. develops & markets advanced photo voltaic solar products. It focuses on the energy sector, including the development, sales and transportation of renewable energy products. The company's business plan is to enter & expand into the solar and related renewable energy. The company was founded in October 1990 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - | - |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Corporate Officer/Principal | - | - |
PFIZER, INC. | Corporate Officer/Principal | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Paula Ragan
Tufts University | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Harvard Medical School | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 14 |
Operativ
Corporate Officer/Principal | 6 |
Director/Board Member | 4 |
Chief Executive Officer | 3 |
Sektoral
Health Technology | 9 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PFIZER, INC. | Health Technology |
X4 PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
St. Lawrence Energy Corp.
St. Lawrence Energy Corp. SemiconductorsElectronic Technology St. Lawrence Energy Corp. develops & markets advanced photo voltaic solar products. It focuses on the energy sector, including the development, sales and transportation of renewable energy products. The company's business plan is to enter & expand into the solar and related renewable energy. The company was founded in October 1990 and is headquartered in Palo Alto, CA. | Electronic Technology |
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA. | Health Technology |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Paula Ragan
- Erfahrung